Efficacy of a Mixed Wavelength Laser for Vaginal Health in Postmenopausal Women: A Randomized Controlled Trial.

Background: syndrome of menopause (GSM) is a chronic and progressive condition. The adverse events (AEs) and contraindications of hormonal therapy have generated interest in vaginal laser treatment. The non-ablative wavelength 1540 nm (GaAs) in this mixed laser synergistically enhances the 10,600 nm (CO2) effect, providing a deeper hyperthermic stimulation of collagen and elastin without damaging the superficial layers.